This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
Align (ALGN) Introduces Intraoral Scanner, Aids iTero Uptake
by Zacks Equity Research
The latest development in Align Technology's (ALGN) iTero arm is expected to be a perfect strategic fit for the company as it will help it further grow its patient base for intraoral scanner.
ABC vs. ALGN: Which Stock Is the Better Value Option?
by Zacks Equity Research
ABC vs. ALGN: Which Stock Is the Better Value Option?
Align Technology (ALGN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $307.66, moving +0.42% from the previous trading session.
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Medical Dental Supplies Industry Outlook: Growth Scope Wide
by Sreyoshi Mukherjee
Near-term prospects look bright for the Zacks Medical Dental Supplies industry, thanks to laser dentistry and robotics.
Align Technology (ALGN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $296.68 in the latest trading session, marking a -0.25% move from the prior day.
Why Is Align Technology (ALGN) Up 3.7% Since Last Earnings Report?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Why Align Technology (ALGN) Could Be Positioned for a Surge
by Zacks Equity Research
Align Technology (ALGN) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Align Technology (ALGN) Is Up 4.12% in One Week: What You Should Know
by Zacks Equity Research
Does Align Technology (ALGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Align Technology's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Align.
LH or ALGN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LH vs. ALGN: Which Stock Is the Better Value Option?
Has Align Technology (ALGN) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Here is Why Growth Investors Should Buy Align Technology (ALGN) Now
by Zacks Equity Research
Align Technology (ALGN) possesses solid growth attributes, which could help it handily outperform the market.
Top Ranked Momentum Stocks to Buy for April 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 26th.
Align Technology (ALGN) Beats on Q1 Earnings, Margins Down
by Zacks Equity Research
Align Technology (ALGN) reports promising top-line numbers on double-digit increase in Invisalign case shipments from a year ago.
What's in Store for Align Technology (ALGN) in Q1 Earnings?
by Zacks Equity Research
Higher Invisalign case volume, solid show by Clear Aligner segment and anticipated sturdy growth at Scanner and Service business are likely to support Align Technology (ALGN) in Q1. However, operating expenses are likely to act as dampeners.
Analysts Estimate Align Technology (ALGN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology (ALGN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $293.08 in the latest trading session, marking a +1.18% move from the prior day.
Align Rides on Firm Global Footprint Despite Fierce Rivalry
by Zacks Equity Research
Align's (ALGN) solid performance in the Europe, Middle East and Africa and Asia-Pacific geographies is appreciative.
Align Technology (ALGN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $273.91, moving +1.84% from the previous trading session.
CAH or ALGN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CAH vs. ALGN: Which Stock Is the Better Value Option?
Align Technology (ALGN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Align Technology (ALGN) closed at $252.33, marking a +1.91% move from the previous day.
Align Technology (ALGN) Partners With Digital Smile Design
by Zacks Equity Research
Align Technology (ALGN) will be integrating Digital Smile Design's methodology in functional and aesthetic dentistry with its end-to-end digital workflow covering iTero scanners and Invisalign system.